Nalcrom (Sodium Cromoglicate)

Sodium cromoglicate, the active ingredient in Nalcrom, is a mast cell stabilizer presented as an oral dosage form for oral use. It is used to prevent symptoms of allergic rhinitis, allergic conjunctivitis, food allergy and asthma in patients requiring prophylactic therapy. GNH USA supplies Nalcrom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nalcrom is a mast cell stabilizer indicated for several allergic and respiratory conditions.

Allergic rhinitis: reduces nasal congestion, sneezing and itching caused by allergen exposure. Allergic conjunctivitis: alleviates eye redness, itching and tearing associated with allergic triggers. Food allergy: helps prevent systemic allergic reactions after ingestion of known allergens. Asthma prophylaxis: decreases frequency of bronchospasm episodes when used as part of a maintenance regimen.

Adverse reactions may occur with oral sodium cromoglicate therapy.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Abdominal pain: occasional cramping or discomfort. - Diarrhea: loose stools, usually transient. - Headache: mild tension‑type headache. - Taste alteration: temporary metallic or bitter taste. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Anaphylaxis: rare severe allergic reaction requiring immediate medical attention. - Severe rash: including Stevens‑Johnson syndrome. - Eosinophilic colitis: inflammation of the colon with eosinophil infiltration. - Hepatic dysfunction: abnormal liver enzymes. - Severe bronchospasm: paradoxical worsening of asthma symptoms. - Angioedema: swelling of face, lips or tongue.

Before initiating therapy, consider the following safety measures.

Pregnancy: consult a healthcare professional to weigh potential risks and benefits. Breastfeeding: discuss possible effects on the infant with a physician. Renal impairment: monitor renal function and adjust therapy if needed. Concomitant medications: review all current drugs for possible interactions. Pediatric use: use with caution in children; dosing is age‑dependent. Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Sodium cromoglicate may interact with other medications; monitor as indicated.

Major Interactions (Avoid): - Systemic corticosteroids: may mask symptom progression, requiring close supervision. - Immunosuppressants: concurrent use can alter immune response, necessitating physician oversight.

Moderate Interactions (Monitor Closely): - Antihistamines: additive effect on symptom control, adjust dosing if needed. - Theophylline: possible alteration of plasma levels; monitor therapeutic range. - NSAIDs: increased risk of gastrointestinal irritation. - ACE inhibitors: monitor for persistent cough or angioedema. - Beta‑agonists: watch for additive bronchodilator effects.